Objective. Rheumatoid synovitis is characterized by an invasive and tissue-destructive infiltrate of lymphocytes, macrophages and synoviocytes. Matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) produced by these cells are important in the remodelling of the articular tissues in rheumatoid arthritis (RA). The aim of this study was to explore whether the serum concentrations of MMPs and their inhibitors were correlated with the histological appearance of the disease.
production in fibroblasts, macrophages and chondrocytes is mediated by synovial macrophages and lymphocytes w6-8x. MMPs are the proteases that participate in the degradation and remodelling of the extracellular matrix. Tissue inhibitors of metalloproteinases (TIMPs) control their action w5, 6, 9x.
Several investigators have shown genetic, histological, biological and clinical heterogeneity of RA w10-14x. However, the associations between the morphological components of RA synovium and biological manifestation remain unclear. There are no histological findings that are typical of RA and distinguish it from other inflammatory arthropathies w3x. The only exception is the formation of T-B cell follicles, which sometimes form germinal-like centres w14-16x. It was also suggested that patients with such focal lymphoid aggregates represented a greater degree of immunological activation and greater potential for articular destruction w14x. Microscopic evaluation of rheumatoid synovium may demonstrate the existence of at least three histological types w17x. Lymphocytic clusters were found in a subgroup of RA patients. Some of these clusters resembled germinal centre-like structures with a central accumulation of B cells surrounded by T cells. A few RA patients had necrobiotic granulomas with a fibrinoid, necrotic centre lined with a collar of histiocytes, rarely with giant cells. The coexistence of follicular synovitis and granulomatous necrobiosis was not observed in the same samples. The remaining patients had only a diffuse infiltrate of mononuclear cells with no further morphological organization w17x.
Each of the histological forms of rheumatoid synovitis might be characterized by a specific pattern of cytokine mRNA expression in the synovium w17x. The purpose of this study was to explore whether serum concentrations of MMPs anduor their inhibitors were also associated with the histological appearance of the disease.
Materials and methods

Patients
Synovial tissue and blood samples were obtained from 37 patients with active RA who met the 1987 American College of Rheumatology criteria for the diagnosis of RA w18x. Tissue specimens were taken during total hip or knee joint replacement surgery. Samples obtained from 30 osteoarthrosis (OA) patients during total hip arthroplasty were used as a control. Table 1 shows the characteristics of the patient groups.
Clinical and laboratory evaluation
The analysis included the duration of morning stiffness, the number of tender joints (Ritchie index) w19x, the number of swollen joints, the erythrocyte sedimentation rate (ESR) and the rheumatoid factor level.
Histopathological assessment
Synovial tissue specimens were stained with haematoxylin and eosin. The density of the cell infiltrate and the topographical organization of mononuclear cells were analysed and classified as described previously w17x. Samples were assessed by one pathologist (BC), who was blind to the clinical and laboratory data.
Serum sample preparation
Blood specimens were clotted for 30 min and then centrifuged for 10 min at 1000 g. Serum aliquots were frozen at 2808C immediately after sample collection.
Measurement of serum MMPs and TIMPs
Serum concentrations of MMP-1, MMP-3, MMP-9, TIMP-1 and TIMP-2 were measured with a quantitative sandwich enzyme-linked immunosorbent assay (ELISA) (Biotrak; Amersham Pharmacia Biotech, Little Chalfont, UK) according to the manufacturer's instructions. The sensitivities were 1.7 nguml for MMP-1, 
Results
Histological evaluation
The morphological analysis of synovial samples from RA patients revealed mononuclear cell infiltrates. These varied in density, were of perivascular and interstitial types and consisted mainly of lymphocyte-and macrophage-like cells. Twenty-two RA synovium tissues presented only diffuse lymphocyte infiltration with no further microanatomical organization. Specimens of this type were categorized as diffuse synovitis. Follicular aggregates of lymphocytes with germinal centre-like structures were present in 15 samples. These tissues were classified as follicular synovitis. In rheumatoid synovia we also found varied capillary neoangiogenesis, proliferation of the synovial lining layer and rare giant-like cells. The formation of necrobiotic granulomas was not observed. The synovial samples from the OA control group were characterized by mild mononuclear cell infiltrates. Figure 1 shows examples from patients with OA and two different subtypes of rheumatoid synovitis.
Clinical and radiological findings No significant differences in sex ratio, age or disease duration were observed between patients with the two morphological types of RA and those with OA. The ESR was higher in the RA than in the OA group (P < 0.001) and higher in patients with follicular synovitis than in those with diffuse infiltration (P < 0.05) ( Table 1 ). The number of swollen joints was higher in patients with the follicular type of RA than in those with the diffuse type (P < 0.01). Radiologically more advanced joint destruction (stage III or IV according to Steinbrocker's criteria) was more frequent in the group of patients with follicular synovitis than in the group with diffuse infiltration (P < 0.05) ( Table 1) . No other clinical parameters of disease activity differed significantly between the histological variants of RA. All patients were receiving non-steroidal antiinflammatory drugs. Sulphasalazine was used in the therapy of five (22.7%) and two (13.3%) RA patients with the diffuse and follicular type of synovitis respectively during the last 3 months before surgery (difference not significant) ( follicular type of synovitis respectively were receiving oral steroids (difference not significant). No patients received steroid injections in last 3 months before surgery.
Serum MMP concentrations
A two-site ELISA sandwich technique was used to measure the serum concentrations of MMPs. Our main interest was whether the levels of MMPs differed between patients with distinct histological types of synovitis. As shown in Fig. 2 , the amounts of MMP-1 in serum were higher in patients with RA and the diffuse and follicular types of synovitis than in OA patients (P < 0.001, P < 0.01 and P < 0.001 respectively). MMP-1 reached the highest concentration in patients with the follicular type of synovitis, differentiating them from those with the diffuse histological type of the disease (P < 0.05).
Like the MMP-1 levels, the serum levels of MMP-3 were elevated in RA and in both morphological forms of synovitis compared with OA (P < 0.001 for all comparisons) (Fig. 3 ). MMP-3 was the dominant metalloproteinase in follicular synovitis and clearly differentiated these patients from those with only diffuse infiltrates (P < 0.01).
Serum levels of MMP-9 were also increased in RA patients and in patients with both histological types of the disease in comparison with OA patients (P < 0.001 for all comparisons) (Fig. 4) . The highest serum concentration of MMP-9 correlated with the presence of follicular lymphocytic aggregates and was greater than the concentration in patients with the diffuse type of disease (P < 0.001). This metalloproteinase distinguished clearly between the two variants of rheumatoid synovitis.
Serum TIMP concentrations
Serum concentrations of TIMPs were also measured with a two-site ELISA sandwich method. Like the MMP levels, the serum levels of TIMP-1 were higher in RA patients and in patients with the diffuse and follicular morphological forms of rheumatoid synovitis than in OA patients (P < 0.001 for all comparisons) (Fig. 5 ). TIMP-1 reached the highest concentration in patients with the follicular type of synovitis and clearly differentiated these patients from patients with diffuse infiltrates (P < 0.05).
Serum concentrations of TIMP-2 were also higher in patients with RA or follicular synovitis than in OA patients (P < 0.01 for both comparisons) (Fig. 6) . However, the TIMP-2 level did not differ significantly between the two histological patterns of RA.
The analysis of the concentrations of metalloproteinases and their inhibitors showed that follicular RA synovitis, contrary to the diffuse form, is associated with relatively high serum concentrations of MMP-1, MMP-3, MMP-9 and TIMP-1. Therefore, serum levels of these MMPs and their inhibitors seem to be associated with the histological manifestation of the disease.
Correlations between clinical data and serum MMP and TIMP levels Table 2 shows the correlations among clinical parameters of disease activity and between these variables and serum MMP and TIMP concentrations in RA patients. The serum levels of MMP-3 were greater in RA and in both morphological forms of synovitis than in OA. MMP-3 was the dominant MMP in follicular synovitis and clearly differentiated these patients from patients with diffuse infiltrates.
As shown in Table 1 , about 64 and 80% of RA patients with diffuse and follicular synovitis respectively were seropositive. No correlations were found between rheumatoid factor and any MMP or TIMP concentration.
Concentration ratios of MMPs to TIMPs
As shown in Table 3 , the calculated concentration ratios of MMP-1 to TIMP-1 or TIMP-2 did not differ significantly between OA and RA patients with the two histological patterns of synovitis. The concentration ratios of MMP-3, MMP-9 and total measured MMPs to TIMP-1, TIMP-2 and total measured TIMPs were higher in RA patients than in OA patients (P < 0.001 for all comparisons), but were especially elevated among patients with the follicular type of rheumatoid synovitis. However, significant differences between the two histological types of RA were observed only for the ratios MMP-9uTIMP-1, MMP-9uTIMP-2 and total MMPsutotal TIMPs (P < 0.05, P < 0.01 and P < 0.05 respectively).
Discussion
Several studies have indicated the genetic, clinical and biological heterogeneity of RA w10-14x. Also, the analysis of RA synovium by conventional histology has revealed the existence of at least three distinct morphological patterns of rheumatoid synovitis w17x. In the previous study w17x, diffuse infiltrates of lymphocytes and macrophages with no characteristic microanatomical organization were found in about half of the samples. One-third of the specimens revealed the presence of lymphocytic aggregates. These structures resembled germinal centres and displayed a central accumulation of B cells surrounded by T cells. Such clusters were surrounded by a diffuse infiltration of mononuclear cells. The presence of such germinal centres in the synovium, which is not a lymphoid tissue, emphasizes the role of the immune system in RA. It also suggests that antigens and antigen recognition are involved in the pathogenesis of this disease w13x. Only a few RA samples displayed the presence of necrobiotic granulomas. In these rare specimens, a collar of histiocytes, sometimes with giant cells, surrounded the fibrinoid necrotic centres w17x. The diffuse type of synovitis was characterized by low levels of transcription of mRNAs for interferon c (IFN-c) , interleukin (IL)-4, IL-1b and tumour necrosis factor a (TNF-a). Specimens categorized as follicular demonstrated elevated production of IFN-c, IL-1b and TNF-a but IL-4 was almost undetectable. The third histological type of synovitis, with necrobiotic granuloma formation, revealed the highest level of transcription of IFN-c, IL-1b, TNF-a and, surprisingly, of IL-4. Diffuse synovitis with a Th0-like cytokine pattern was observed among patients with less active RA, 50% of whom were seronegative for the presence of rheumatoid factor. The Th0 pattern of cytokine production suggests that the T-cell response was not highly differentiated in these patients. The follicular type of synovitis, in which there was a Th1-like pattern of cytokine production, was characteristic of seropositive patients with more active disease. Least common was granulomatous synovitis with a mixed Th1uTh2 cytokine pattern, which was found in a group of patients who were mostly seropositive and had the most active RA w17x.
In the present study, we were able to distinguish only two of the morphological forms of rheumatoid synovitis described in the report referred to above w17x. Almost two-thirds of the RA synovium tissues were characterized by diffuse mononuclear cell infiltrates with no further microanatomical organization. Follicular clusters of lymphocytes with germinal centre-like structures were found in the remaining specimens. We did not find necrobiotic granulomas. However, in the previous study w17x these were very rare.
MMPs and TIMPs play an important role in the remodelling of the articular tissues w4 -6, 9x. MMPs are responsible for the proteolytic degradation of extracellular matrix components. They are produced by several types of cell, such as chondrocytes, fibroblasts and macrophages w5-7, 20x. It was demonstrated that their synthesis is stimulated by cytokines such as IL-1 and TNF-a w5, 6, 21x. The action of MMPs is regulated by TIMPs, the production of which is stimulated by cytokines such as transforming growth factor b, IL-6 and IL-11 w5, 6, 22x. The aim of the present study was to explore whether the serum concentrations of MMPs and their inhibitors are associated with the histological appearance of the disease. Our main interest was whether the concentrations of MMPs anduor TIMPs might identify patients with distinct morphological types of rheumatoid synovitis. Interstitial collagenase (MMP-1), produced mainly by synovial fibroblasts w20, 23x, plays an important role in the degradation of articular cartilage and synovium w5, 6, 9x. Previous investigators have shown that, in RA, MMP-1 is present not only in synovium w20, 24, 25x but also in synovial fluid w25x and serum w23, 25x. However, only some of the previous work has shown that its concentration in RA synovial fluid w26x or serum w27, 28x differs significantly from concentrations in controls. That MMP-1 is expressed not only in patients with established erosive RA but also in patients with early arthritis implies that this protease may serve as a marker of the very early stage of the disease w29x. Our study confirms that the level of MMP-1 in serum is elevated in RA patients. Furthermore, we found that MMP-1 reached its highest concentration in patients with the follicular type of synovitis, differentiating them from those with diffuse synovitis.
We also demonstrated that the serum concentration of this protease correlated with MMP-3, MMP-9 and clinical markers of disease activity, such as ESR and the duration of morning stiffness. Among the group of 15 patients with the follicular type of the disease and with more advanced joint destruction, we also found significant correlations between the serum level of MMP-1 and the Ritchie index (r = 0.573, P = 0.0252) and the number of swollen joints (r = 0.555, P = 0.0312) (data not shown). In the case of patients with the diffuse type of synovitis and for all 37 RA patients, these correlations were not significant (data not shown). Therefore, MMP-1 may be more a marker of joint damage than of disease activity.
Stromelysin-1 (MMP-3) is known to degrade components of the extracellular matrix, including proteoglycans, gelatin, fibronectin, laminin and various types of collagens w5, 6, 9, 23x. It is also an activator of proMMPs, such as MMP-1 and MMP-9. This protease is produced mainly by fibroblasts w20x. Several studies have revealed that MMP-3 in RA is expressed in large amounts in synovium w20, 24x, synovial fluid w26x and serum w23, 27, 28, 30-32x. It was also shown that the concentration of MMP-3 in RA synovial fluid correlated with that in serum w32-34x. Therefore, the serum concentration of MMP-3 may be a useful marker of inflammation activity in the joints of patients with RA. In our study, the serum level of MMP-3, like that of MMP-1, was also greater in RA than in OA patients. In particular, MMP-3 was the dominant metalloproteinase in follicular synovitis and could differentiate these patients clearly from those with only diffuse infiltrates. It was shown that the serum MMP-3 concentration correlated with the ESR and swollen joint count w30, 35, 36x. We demonstrated that the serum concentration of MMP-3 is also associated with the duration of morning stiffness, the Ritchie index and MMP-1 and MMP-9 concentrations. Others have also shown a correlation of MMP-1 with MMP-3 in RA synovial fluid w26x. These results suggest that the follicular histological form of RA can be considered as the more active form of the disease, and that the MMP-3 concentration could be a useful marker for identifying this form of RA. The levels of MMP-3 in the serum of RA patients, even during the early stages of the disease, were higher than those in controls, and appeared to increase as the disease progressed w32, 37, 38x. This suggests that the assessment of serum MMP-3 may be an important tool in the diagnosis of early onset of RA. Suppression of MMP-3 production might be an effective therapeutic approach for patients with early RA.
The serum concentration of gelatinase B (MMP-9), produced mainly by granulocytes w7, 39x, was elevated in RA in comparison with OA patients. Other studies showed that MMP-9 was abundant in the RA synovium w7, 40x and found that its levels were increased in RA synovial fluid w7, 26, 40x and serum w7, 40x compared with controls. In our study the highest serum concentration of MMP-9 correlated with the presence of the follicular form of synovitis, in which the concentration was greater than in patients with the diffuse type of disease. This MMP discriminated clearly between these two variants of rheumatoid synovitis. Correlation of MMP-9 with disease activity markers such as ESR and the number of swollen joints seems to confirm the suggestion that RA is more severe in patients with the follicular type of synovitis.
The activity of MMPs is regulated by proenzyme production anduor by the activation of their endogenous inhibitors. There are at least two TIMPs. TIMP-1, the most widely distributed one, suppresses the activity of all MMPs w5, 6x. The presence of TIMP-1 in synovium w5, 6x and in increased amounts in RA synovial fluid w26, 32x or serum w23, 27, 32x has been shown in other studies. On the other hand, some investigators detected very similar levels of TIMP-1 in sera of RA and OA patients w28, 30x. In the present work we showed that the serum levels of TIMP-1, like those of the MMPs we studied, were elevated in RA patients compared with OA patients. Furthermore, TIMP-1 reached its highest concentration in patients with the follicular type of synovitis. Other studies showed that TIMP-1 correlated with ESR w30x. In our study it also correlated with the Ritchie index and the number of swollen joints. Up-regulation of TIMP-1 synthesis, especially in patients with the follicular form of rheumatoid synovitis, might be responsible for the suppression of synovium and cartilage destruction in patients with severe activity of the disease.
Like concentrations of TIMP-1, serum concentrations of TIMP-2 were also higher in patients with RA and with follicular synovitis than in OA patients. However, the TIMP-2 level did not differ significantly between the two histological patterns of RA. Others have also shown a higher serum concentration of TIMP-2 in RA than in controls w27x.
Some studies suggest that the articular destruction in RA may be caused by the alteration in the balance between MMPs and TIMPs in favour of MMPs w7, 26, 33x. In our study, the calculated concentration ratios of MMP-3, MMP-9 and the ratios of total measured MMPs to TIMP-1, TIMP-2 and total measured TIMPs were higher in RA patients than in OA patients. They were especially increased in patients with follicular synovitis. However, significant differences between the morphological forms of RA were observed only for the ratios MMP-9uTIMP-1, MMP-9uTIMP-2 and total MMPsutotal TIMPs. The analysis of ratios of individual MMPs or total measured MMPs to individual TIMPs or total measured TIMPs suggests that the relative production of TIMPs is decreased in RA compared with OA, especially in patients with the follicular type of synovitis. These data should be considered cautiously because we did not measure other proteinases that may be involved in the process of articular tissue destruction, or other inhibitors.
Radiological analysis demonstrated that more advanced joint destruction was more frequent among patients with follicular synovitis, characterized by higher levels of MMPs and TIMP-1 measured by us. Other investigators have also observed correlations of serum concentrations of MMP-3 and TIMP-1 with disease progression w32x.
The analysis of the treatment regimens revealed that methotrexate (MTX) was more often used by patients with follicular synovitis than by those with diffuse synovitis. There is evidence that MTX may decrease the density of the mononuclear cell infiltration in RA synovium w41-42x. It was suggested that MTX has an antiangiogenic effect and may reduce joint inflammation through the suppression of the growth of small blood vessels in the synovium, which is related to mononuclear cell migration and the proliferation of synovial tissue w43-45x. However, there is also evidence that MTX does not influence cell density significantly in rheumatoid synovium w46, 47x. Moreover, it has also been shown that the density of the mononuclear cell infiltrate is higher in RA patients treated with MTX w48x. We are unaware of any data suggesting an effect of MTX on the formation of follicular structures in rheumatoid synovium.
Methotrexate has also been shown to reduce MMP-1 and MMP-3 production w46, 47, 49x and increase TIMP-1 production w50x. However, some studies suggest that MTX does not have a significant influence on MMP-3 w46x or TIMP-1 production w46, 49x. In our study we found that measured serum concentrations of MMPs and TIMPs and MMPuTIMP ratios were higher in patients with the follicular type of synovitis than in those with diffuse synovitis. This was observed despite more frequent MTX treatment in the group of patients with the follicular form than in those with the diffuse histological form of RA. Therefore, we surmise that the more frequent use of MTX in our patients with follicular than in the group with diffuse synovitis simply suggests greater activity of the disease in the former group of patients.
There were no other significant differences in treatment between the two RA groups that could have influenced the histological appearance of rheumatoid synovitis or the production of MMPs or TIMPs. No patients had received steroid injections in the 3 months before surgery.
Our finding that the distinct morphological appearances of synovitis are associated with different levels of serum MMPs and TIMP-1 confirms the heterogeneity of RA. We also observed correlations of serum MMP and TIMP concentrations with laboratory and clinical parameters of disease activity. Therefore, not only are MMP-1, MMP-3, MMP-9 and TIMP-1 good indicators of disease activity in RA but they might also predict the histological manifestation of the disease. The distinct histological, metalloproteinase and TIMP-1 patterns observed in RA patients in our study suggest the possibility of different responses to therapy regimens. However, a longitudinal study of patients at various stages in the disease process is clearly indicated.
